DURECT NASDAQ DRRX
$6.22 -0.29 -4.66%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 17 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

14.17B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

14.14B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.24
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

2.28B
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

79.77 %
Upcoming events DURECT All events
No upcoming events scheduled

Stock chart DURECT

Stock analysis DURECT

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-444.51 -64.31
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
178.66 43.28
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-474.71 -66.87
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.86 0.90
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-91.44 -12.49

Price change DURECT per year

1.17$ 2.95$
Min Max

Summary analysis DURECT

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure DURECT

Revenue and net income DURECT

All parameters

About company DURECT

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Address:
10260 Bubb Road, Cupertino, CA, United States, 95014-4166
Company name: DURECT
Issuer ticker: DRRX
ISIN: US2666051048
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2000-09-28
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.durect.com

On which stock exchange are DURECT (DRRX) stocks traded?

DURECT (DRRX) stocks are traded on NASDAQ.

What is the ticker of DURECT stocks (DRRX)?

The stock ticker of DURECT’s stocks or in other words, the code is DRRX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does DURECT (DRRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, DURECT (DRRX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are DURECT (DRRX) stocks traded?

DURECT (DRRX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of DURECT (DRRX) stocks today?

The current price of DURECT stocks on 02.02.2023 is 6.22 dollars. per share.

What is the dynamics of DURECT (DRRX) stocks from the beginning of the year?

DURECT (DRRX) quotes have increased by 10.48% from the beginning of the year up to 6.22 dollars. per 1 stocks.

How much did DURECT (DRRX) stocks increase in феврале 2023?

This month DURECT (DRRX) quotes have increased by 0% to 6.22 dollars. per share.

How much are DURECT (DRRX) stocks worth?

Today, on October, 02.02.2023 DURECT’s (DRRX) stocks cost 6.22 dollars..

What is the market capitalization of DURECT (DRRX)?

Capitalization is the market value of DURECT (DRRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.02.2023, the market capitalization of DURECT (DRRX) is estimated at about 14167542800 dollars.